
<?php include("includes/_header.php"); ?>
<body>

<section class="child-header-container">
  <div class="row">
    <div class="large-12 columns">
      <h1 class="hero-title">Leader In Optogenetics</h1>
      <h2 class="header-subtitle">The industry leader in optogenetics developing breakthrough therapeutic interventions transforming the field of drug discovery</h2>
    </div>

  </div>
</section>

<section class="collaborations">
	<div class="row">
    <div class="large-12 columns">
      <h2 class="section-header">Collaborations</h2>
      <h5 class="section-subheader">Circuit Therapeutics and Boehringer Ingelheim announce signature of a research partnership agreement to discover new approaches to treating psychiatric disorders.</h3>
    </div>
  </div>

  <div class="centered-btn">
    <a href="news.php" class="button radius centered-btn">Learn More</a>
  </div>
</section>

<section class="the-team about">
  <div class="row">
    <div class="large-12 columns">
      <h2 class="section-header blue">The Team</h2>
      <h5 class="section-subheader">Incredible advancements in neuroscience that has allowed for ways to control the human nervous system to beat genetic disorders and deficiencies.</h3>
    </div>
  </div>
  <div class="row">
    <div class="large-10 large-offset-2 columns">
      <ul class="small-block-grid-1">
      <li>
        <img class="team-pic" src="assets/images/team/fred-moll.png">
        <div class="person-about"> 
          <h5 class="name">Fred Moll, <span>MD, PHD</span></h5>
          <h6>CEO and Chairman of the Board</h6>
          <p>Dr. Moll is an entrepreneur with formidable experience in the area of medical devices. He founded Intuitive Surgical, the world leader in surgical robotics, and has since founded Hansen Medical and Auris Surgical Robotics. Dr. Moll also founded Origin Medsystems, Inc, which later became an operating company within Guidant Corporation. He is currently on the boards of several influential healthcare companies. Dr. Moll holds a BA from the University of California, Berkeley, an MS from Stanford University, and an MD from the University of Washington School of Medicine.</p>
        </div>
      </li>
      <li>
        <img class="team-pic" src="assets/images/team/karoly.png">
        <div class="person-about"> 
          <h5 class="name">Karoly Nikolich, <span>PHD</span></h5>
          <p>Dr. Nikolich is Founder of Circuit Therapeutics and has been with the company since its inception. He has extensive experience in biotechnology companies, primarily in the area of neuroscience. Dr. Nikolich previously led work in neuroscience at Genentech, was VP of Research at Lynx Therapeutics, and has founded and led companies, including AGY Therapeutics, Neurofluidics, and Amnestix. He is a Consulting Professor at Stanford University, serves on the boards of several companies, and is an advisor to venture funds. Dr. Nikolich conducted his doctoral studies at Eötvös University of Sciences in Budapest, Hungary, and postdoctoral research at Tulane University and at UCSF.</p>
        </div>
      </li>
      <li>
        <img class="team-pic" src="assets/images/team/mike.png">
        <div class="person-about"> 
          <h5 class="name">Michael Kaplitt, <span>MD, PHD</span></h5>
          <p>Dr. Kaplitt is an internationally recognized expert in gene therapy and molecular neurobiology.  He co-developed the use of AAV technology for gene transfer in the nervous system more than 20 years ago, and as a practicing neurosurgeon he also performed the first human gene therapy for Parkinson’s Disease. He retains his laboratory at Weill Cornell Medical College where he also continues to perform functional neurosurgery procedures in addition to leading scientific activities at Circuit Therapeutics.  Dr. Kaplitt has received numerous awards for both his research and clinical work.  After completing an undergraduate degree in molecular biology and Russian Studies, he received his PhD from Rockefeller University and his MD from Cornell Medical College. Dr. Kaplitt joined Circuit Therapeutics in 2013.
        </p>
        </div>
        </li>
      <li>
        <img class="team-pic" src="assets/images/team/steven.png">
        <div class="person-about"> 
          <h5 class="name">Steven Braithwaite, <span>PHD</span></h5>
          <p>Dr. Braithwaite joined Circuit Therapeutics in 2012. He previously led drug discovery at Signum Biosciences, headed the cellular neurodegeneration group at Wyeth Research/Pfizer, and was a program leader at AGY Therapeutics. Dr Braithwaite received his PhD from the University of Bristol, UK and performed postdoctoral work at Stanford University, he has published extensively in the fields of basic neuroscience research, Alzheimer’s and Parkinson’s disease. He is involved with the Michael J Fox Foundation for Parkinson’s Disease Research and the Alzheimer’s Drug Discovery Foundation as well as reviewing grants and publications from multiple organizations.</p>
        </div>
      </li>
      <li><img class="team-pic" src="assets/images/team/dan.png">
       <div class="person-about"> 
         <h5 class="name">Dan Andersen</h5>
          <p>Dan Andersen joined Circuit Therapeutics in 2012. He was previously Co-Founder and Director of Research of OptiMedica Corporation, Manager of Advanced Studies at Lumenis Ltd., and Co-Founder of Sciton, Inc.  Dan, an expert in light-tissue interaction and device development, received his BS in Physics from the University of Arizona, Tucson.
          </p>
        </div>
      </li>

      </ul>
    </div>
  </div>

</section>


<section class="the-team advisors">
  <div class="row">
    <div class="large-12 columns">
      <h2 class="section-header">Scientific Advisors</h2>
      <h5 class="section-subheader">Lorem ipsum dolor sit amet, consectetur adipisicing elit. Culpa, vel, vero, necessitatibus aliquam porro excepturi sapiente hic placeat neque libero ut dolore commodi quibusdam eligendi alias sit ipsum in laudantium!</h3>
    </div>
  </div>
  <div class="row">
    <div class="large-12 columns">
      <ul class="large-block-grid-2 alternate-grid-large">
      <li>
        <div class="person-container">
          <img class="advisor-pic" src="assets/images/advisors/karl.png">
            <div class="right-about">
             <h5 class="name">Karl Deisseroth, <span>MD, PhD</span></h5>
            <p>Dr. Deisseroth is the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University. His pioneering work has been at the foundation of the field of optogenetics, opening up new ways to understand neural circuit function and dysfunction in neurological and psychiatric disease. He is a Howard Hughes Medical Institute Investigator, a member of the National Academy of Sciences, and has received prestigious awards, including the Nakasone Prize. Dr. Deisseroth received his PhD and MD from Stanford University. He is a Co-Founder of Circuit Therapeutics.</p>
          </div>
        </div>
      </li>
      <li> 
        <div class="person-container">
         <img class="advisor-pic" src="assets/images/advisors/scott.png">
            <div class="right-about">
            <h5 class="name">Scott Delp, <span>PhD</span></h5>
            <p>Dr. Delp is the James H. Clark Professor at Stanford University in the Departments of Bioengineering, Mechanical Engineering, and, by courtesy, Orthopedic Surgery. He is Founding Chair of the Department of Bioengineering and Co-Director of the Center for Biomedical Computation at Stanford University.  Dr. Delp’s work draws on computational mechanics, medical imaging, and neuromuscular biology to improve treatments for neurologic and musculoskeletal diseases. His highly realistic simulations of the musculoskeletal system have been used to study neural control of movement and mechanisms of musculoskeletal diseases and to design surgeries and medical devices.  He received his PhD from Stanford University in Mechanical Engineering. Dr. Delp is a Co-Founder of Circuit Therapeutics.</p>
          </div>
        </div>
      </li>
      <li>
         <div class="person-container">
        <img class="advisor-pic" src="assets/images/advisors/anatol.png">
            <div class="right-about">
            <h5 class="name">Anatol Kreitzer, <span>PhD</span></h5>
            <p>Dr. Kreitzer is Associate Professor of Physiology and Neurology at University of California, San Francisco and Associate Investigator at the Gladstone Institute.  His research focuses on understanding the function of the basal ganglia, particularly in the context of disorders including Parkinson’s Disease. He has published in high profile journals and was honored with the Young Investigator Award from the Society of Neuroscience. Dr. Kreitzer earned his PhD at Harvard University and conducted postdoctoral research at Stanford University.</p>
          </div>
        </div>
      </li>

           <li>
        <div class="person-container">
          <img class="advisor-pic" src="assets/images/advisors/rob.png">
            <div class="right-about">
            <h5 class="name">Rob Malenka, <span>MD, PhD</span></h5>
            <p>Dr. Malenka is the Nancy Friend Pritzker Professor in Psychiatry & Behavioral Sciences at Stanford University and is Deputy Director of the Stanford Neurosciences Institute.  He was the former co-Director at the Stanford Institute for Neuro-Innovation and Translational Neurosciences at the Stanford University School of Medicine and Associate Chair of the Department of Psychiatry and Behavioral Sciences.  Dr. Malenka has been elected as a Member of the National Academy of Sciences, amongst other prestigious honors. His work focuses on understanding molecular mechanisms of synaptic plasticity and synaptic mechanisms underlying addiction and psychiatric disorders. He received his PhD and MD from Stanford University School of Medicine. Dr Malenka is a Co-Founder of Circuit Therapeutics.</p>
          </div>
        </div>
      </li>
           <li>
        <div class="person-container">
           <img class="advisor-pic" src="assets/images/advisors/thomas.png">
            <div class="right-about">
            <h5 class="name">Thomas Südhof, <span>MD</span></h5>
            <p>Dr. Südhof is a renowned scientist, winner of the Nobel Prize in Physiology or Medicine 2013, for his fundamental work understanding neuronal communication. Dr. Südhof is the Avram Goldstein Professor in the Stanford University School of Medicine and Professor, by courtesy, of Neurology and of Psychiatry and Behavioral Sciences; he is also a Howard Hughes Medical Institute investigator.  He was formerly at the University of Texas Southwestern Medical Center at Dallas, earned his MD from Georg-August-Universität in Göttingen and performed postdoctoral studies at the Max Planck Institute for Biophysical Chemistry. He has received numerous honors including the Nobel Prize (2013), the Lasker Award (2013), and the Kavli Prize (2010), and he is a Member of the National Academy of Sciences. Dr. Südhof is a Co-Founder of Circuit Therapeutics.</p>
          </div>
        </div>
      </li>
      </ul>
    </div>
  </div>
</section>

<section class="bottom-action">
  <div class="row">
    <div class="large-12 columns">
      <h2 class="section-header">Get in Touch</h2>
      <h5 class="section-subheader">Have questions or simply looking to find out more about partnering with us? Pick up the phone or send a quick message to find out more about our vision or partnering with us.</h3>
    </div>
  </div>

  <div class="centered-btn">
    <a href="#" class="button centered-btn radius">Contact Us</a>
  </div>
</section>



<?php include("includes/_footer.php"); ?>
</body>
</html>